Technology Avacta Appoints Dr Christina Coughlin as Non-Executive Director AIT News Desk Mar 22, 2022 Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its…
Life Sciences Inceptor Bio Launches Next-Generation CAR-T, CAR-M, And NK/NKT Platform Focused On Advancing Cell… AIT News Desk Jul 6, 2021 -- Inceptor Bio is developing multiple next-generation cell therapy platforms to cure difficult-to-treat cancers with a focus on novel mechanisms to…